Die ganze Ausschreibung von C028 (FCRS = CH028) Novartis Pharma AG
Das ist der Job
In addition, we provide flexible and hybrid working options, where possible, and minimum 14 weeks paid parental leave.
Darum lohnt es sich
Our aspiration at Novartis is to grow by ensuring every patient has access to the medicine they need as soon as possible. /ppThe Director International, Haematology will lead the development and implementation of the International cross-functional launch and growth strategy for a priority myelofibrosis asset.
This role will work in close partnership with priority International markets and Regions, and with International Medical Affairs, Value Access, Customer Market Activation, Integrated Insights, Launch Excellence Execution, Business Operations, Patient Engagement, Communications and global teams.
The role serves as a primary commercial interface for markets, connecting strategy, evidence, customer insight and launch execution. /ph3Job Description Key Responsibilities /h3ulliLaunch strategy and One Brand Plan. /liliOwn the International commercial launch strategy and co-lead the cross-functional One Brand Plan, defining the strategic imperatives, must-wins, priority customer opportunities and critical execution choices for International markets. /liliPartner with priority markets and Regions to localise and operationalise strategy, remove launch barriers, capture insights and establish a tiered support model with clear accountabilities, milestones and escalation paths. /liliLead the evolution of the asset positioning, master story, core messages and differentiation strategy, ensuring a compelling, evidence-based narrative across commercial, medical and access stakeholders. /liliDrive segmentation, customer journeys, engagement planning, campaign development, field-force enablement, training and go-to-market choices in partnership with Customer Market Activation, Integrated Insights and country teams. /liliMaintain an integrated view of the current and emerging myelofibrosis landscape; translate competitor events, market research and customer insights into strategic choices, objection handling and agile response plans. /liliLead launch governance, readiness reviews, KPI and launch tracking, investment prioritisation and management updates.
Ensure risks, dependencies and decisions are visible and acted upon early. /liliAct as the International commercial partner for Value Access, helping shape the payer value story, evidence priorities, HTA/JCA readiness, pricing strategy and country reimbursement preparation. /liliLead through influence across global, International, regional and country teams; create clarity, pace and accountability while fostering an enterprise mindset and high-performing team culture. /liliCo-own brand investment choices and commercial forecasts, challenge assumptions and connect resources to the highest-value launch outcomes. /li /ulh3Essential Requirements /h3ulliMinimum 10 years of relevant experience across commercial, marketing, sales, launch strategy, medical affairs and/or value access, with significant experience in oncology or haematology. /liliAdvanced degree in business, life sciences, medicine or a related discipline. /liliDemonstrated success leading the commercialisation of an asset across the lifecycle, including pre-launch and launch, in both above-country and in-market settings. /liliStrong launch leadership in a complex, competitive environment, with the ability to turn strategy into disciplined execution and measurable outcomes. /liliExperience working directly in, or in close partnership with, priority International markets; recent exposure to Germany, Japan and/or China is highly valued. /li /ulh3Preferred Requirements /h3ulliDirect experience in malignant haematology, myelofibrosis or myeloproliferative neoplasms. /liliRecent global or International launch experience for a specialty medicine or combination therapy. /liliExperience shaping an innovative market, changing treatment ambition and building advocacy before launch. /liliCountry-level business leadership and meaningful PL experience; recent PL ownership is highly valued. /liliExperience with HTA, access and reimbursement challenges for oncology combination therapies. /li /ulh3Benefits Rewards /h3pAt Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen. /ppExpected Annual Base Salary Range for role: 154,700.00 - 287,300.00 CHF.
The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs.
Further details will be provided during the application process. /ppNote: Benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable. /ppA full overview of your compensation package, including any relevant collective bargaining agreement details applicable to your role based on your employment location and Novartis employer entity, will be communicated separately to you during the application process. /ph3Pay Equity Statement /h3pPay equity is a fundamental principle of our employment policy and reflects our commitment to create a diverse, equitable and inclusive environment that treats all employees with dignity and respect, as outlined in our Code of Ethics. /ph3Commitment to Diversity and Inclusion /h3pNovartis is committed to building an outstanding, inclusive work environment and diverse teams’ representative of the patients and communities we serve. /ph3Why Novartis /h3pHelping people with disease and their families takes more than innovative science.
It takes a team of people like you. /p /p ph3Job Description Summary #LI-Hybrid /h3pSalary Range: CHF154,700.00 - CHF287,300.00 Location: Basel, Switzerland /ppWelcome to where we thrive together!
The role is accountable for translating our ‘One Brand Plan’ into focused market-facing strategies, launch deliverables and execution guidance that maximise patient access, establish the combination as a future standard of care and deliver sustainable commercial success.
The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically.
In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. Long-term equity awards granted at group level may also be part of your package.
It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives.
Ready to create a brighter future together? /ppWe also have a note: Novartis is aware of employment scams which make false use of our company name or leader’s names or recruiter’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money.
If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.
Novartis is not responsible for any claims, losses, damages, or expenses resulting from scams. /ppIn the context of China Cross-Border Data Transfer (CBDT) policy, if you need to apply for a position in China, please go to the local Recruiting System TaleNov. /ph3Skills Desired /h3ulliAsset Management /liliBusiness Development /liliCommercial Excellence /liliCross-Functional Collaboration /liliDigital Marketing /liliInfluencing Skills /liliInspirational Leadership /liliKey Account Management /liliMarket Access /liliMarket Share /liliMarket Trends /liliPeople Management /liliProduct Launches /liliProduct Lifecycle Management (PLM) /liliProfit and Loss (PL) /liliSales /liliStakeholder Engagement /liliStakeholder Management /liliValue Propositions /li /ulpImproving the lives of people living with disease takes more than innovative science.
It takes a focus on the needs of people and a community committed to meeting them.
Bereit?
Bewerbung wird direkt an C028 (FCRS = CH028) Novartis Pharma AG übergeben — kein Konto nötig.